Identification of potent human neutralizing antibodies against SARS-CoV-2 implications for development of therapeutics and prophylactics

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a novel coronavirus that is spreading rapidly, which seriously impacts global public health and economy. Thus, developing effective drugs remains urgent. We identify two potent antibodies, nCoVmab1 and nCoVmab2, targeting the SARS-CoV-2...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhao, Shaojuan, Zhang, Huajun, Yang, Xinglou, Zhang, Haiwei, Chen, Ying, Zhan, Yancheng, Zhang, Xiaoqing, Jiang, Rendi, Liu, Meiqin, Liu, Lan, Chen, Li, Tang, Wei, Peng, Cheng, Gao, Xiaoxiao, Zhang, Zhe, Shi, Zhengli, Gong, Rui
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Nature Publishing Group UK 2021
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352940/
https://www.ncbi.nlm.nih.gov/pubmed/34373446
http://dx.doi.org/10.1038/s41467-021-25153-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8352940/
https://www.ncbi.nlm.nih.gov/pubmed/34373446
http://dx.doi.org/10.1038/s41467-021-25153-x

Ejemplares similares